Haag C, Ehninger G
Medizinische Klinik I, Universitätsklinikum Carl-Gustav-Carus der Technischen Universität Dresden, Germany.
Z Gastroenterol. 2002 Apr;40 Suppl 1:S68-S70. doi: 10.1055/s-2002-23615.
During the last years the chemotherapy in osophageal, stomach and pancreatic cancer demonstrated some success. Radiochemotherapy for esophageal cancer is indicated as neoadjuvant therapy before surgery in locally advanced cancer or in patients with other diseases, which do not allow surgery. In stomach cancer patient there is a clear indication for chemotherapy in metastatic disease and within clinical trials as neoadjuvant chemotherapy in locally advanced cancer. In pancreatic cancer patient the chemotherapy shows less success comparing to other gastrointestinal cancer; it is part of the palliative concept with other therapeutic strategies.
在过去几年中，食管癌、胃癌和胰腺癌的化疗取得了一些成效。食管癌的放化疗适用于局部晚期癌症或患有其他疾病而无法进行手术的患者术前的新辅助治疗。对于胃癌患者，转移性疾病的化疗有明确指征，在局部晚期癌症的临床试验中，化疗作为新辅助化疗也有明确指征。与其他胃肠道癌症相比，胰腺癌患者的化疗成效较低；它是与其他治疗策略相结合的姑息治疗理念的一部分。
